The short version of Visceral adiposity fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-15 and is reviewed periodically as new material appears.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Practical handling centers on limiting moisture, oxygen, and temperature excursions. Lyophilized material is generally held at or below minus twenty degrees Celsius, protected from light and kept sealed until use. Once reconstituted, solutions are typically kept cold and used within a short window because hydrolysis and microbial growth both accelerate in liquid form. Repeated freeze-thaw cycles are avoided, since they promote aggregation. Vial contents should be inspected for particulates and clarity before analysis, and working aliquots are prepared to reduce the number of times the stock is opened.
Quantitation of the peptide relies mainly on reversed-phase high-performance liquid chromatography with ultraviolet detection, typically at 214 nanometers, where the peptide bond absorbs. Identity is confirmed by mass spectrometry, most often electrospray ionization coupled to liquid chromatography, and by peptide mapping after enzymatic digestion. Because related impurities differ only slightly in sequence or modification, method development emphasizes resolution rather than speed. Purity is usually reported as a percentage of the main peak area, with individual impurities listed separately when they exceed a defined reporting threshold.
=== Bones, joints, frailty, posture and in people at risk === Strength training also provides functional benefits. Stronger muscles improve posture, provide better support for joints, and reduce the risk of injury from everyday activities. Progressive resistance training may improve function, quality of life and reduce pain in people at risk of fracture, with rare adverse effects. Weight-bearing exercise also helps to prevent osteoporosis and to improve bone strength in those with osteoporosis. For many people in rehabilitation or with an acquired disability, such as following stroke or orthopaedic surgery, strength training for weak muscles is a key factor to optimise recovery. Consistent exercise can actually strengthen bones and prevent them from getting frail with age.
== Further reading == David A. Epstein, Left, Right, Out: The History of Third Parties in America. Arts and Letters Imperium Publications. 2008. Alan Feuer, "Inside Socialist Party Headquarters". The New York Times. October 20, 2008. R. W. Tucker, "The Debs Caucus: A Party Within a Party". Madison, WI. Socialist Party of Wisconsin. December 1970.
Pentetic acid or diethylenetriaminepentaacetic acid (DTPA) is an aminopolycarboxylic acid consisting of a diethylenetriamine backbone with five carboxymethyl groups. The molecule can be viewed as an expanded version of EDTA and is used similarly. It is a white solid with limited solubility in water.
, then humanity's energy consumption will exceed the incident solar power (1.742×1017 W) after 240 years, the total power of the Sun (3.826×1026 W) after 800 years, and that of the Galaxy (7.29×1036 W) after 1,500 years. Based on this calculation, Zuckerman estimates the number of civilizations that could exist in our galaxy at 10,000. Kardashev concludes that the current exponential growth is a transitional phase in the development of a civilization, and that it is inevitably limited by natural factors. In fact, he believes that the required mass and energy will continue to grow exponentially for another 1,000 years. Civilization is thus defined by an exponential rate of increase. Humanity as a model for thinking about the development of extraterrestrial civilizations has its limitations, which can be truly overcome by a multidisciplinary approach according to the work of Kathryn Denning.
Sources: en.wikipedia.org
Each e-cigarette company's designs generate different amounts of heating power. The evidence indicates that larger capacity tanks, increasing the coil temperature, and dripping configurations seem to be end-user-modified designs adopted by e-cigarette companies. Variable voltage e-cigarettes can raise the temperature within the device to allow users to adjust the e-cigarette vapor. No firm information is available on the temperature differences in variable voltage devices. The length of time that the e-cigarette vapor is being heated within the device also affects the e-cigarette vapor properties. When the temperature of the heating element rises, the temperature of the e-cigarette vapor in the air rises. The hotter air can support more e-liquid air density. E-cigarettes have a wide array of engineering designs. The differences in e-cigarette manufacturing materials are broad and often unknown. Concern exists over lack of quality control. E-cigarette companies often lack manufacturing standards or are non-existent. Some e-cigarettes are designed and manufactured to a high standard. The manufactured standards of e-cigarettes are not equivalent to pharmaceutical products. Improved manufacturing standards could reduce the levels of metals and other chemicals found in e-cigarette vapor. Quality control is influenced by market forces. The engineering designs typically affect the nature, number, and size of particles generated.
differentiation The process by which a eukaryotic cell changes from one cell type to another, in particular from a non-specialized stem cell to a more specialized cell type which is then said to be differentiated. This usually occurs by a carefully regulated series of epigenetic modifications which change the specific set of genes expressed by the cell, turning certain genes "off" and others "on". These modifications result in a cascade of phenotypic changes which can dramatically alter the cell's size, shape, metabolism, membrane properties, and rate of division, and therefore its functions, behaviors, and responsiveness to signals, permitting multicellular organisms to create a huge variety of functionally distinct cell types from a single genome. Differentiation occurs repeatedly during an organism's development from a single-celled zygote into a complex multicellular system of tissues and cell types, and continues to some extent after the organism reaches maturity in order to repair and replace damaged and dying cells. In most cases differentiation is irreversible, though some cells may also undergo dedifferentiation in specific circumstances.
== Structure == LCRs were originally thought to be unstructured and flexible linkers that served to separate the structured (and functional) domains of complex proteins, but they are also capable of forming secondary structures, like helices (more often) and even sheets. They may play a structural role in proteins such as collagens, myosin, keratins, silk, cell wall proteins. Tandem repeats of short oligopeptides that are rich in glycine, proline, serine or threonine are capable of forming flexible structures that bind ligands under certain pH and temperature conditions. Proline is a well-known alpha-helix breaker, however, amino acid repeats composed of proline may form poly-proline helices.
== Retirement == Heseltine stood down from his Henley constituency at the 2001 election, being succeeded by Spectator editor and future prime minister Boris Johnson, but he remained outspoken on British politics. He was created a life peer on 12 July 2001 taking the title Baron Heseltine, of Thenford in the County of Northamptonshire. In December 2002 Heseltine controversially called for Iain Duncan Smith to be replaced as leader of the Conservatives by the "dream-ticket" of Clarke as leader and Michael Portillo as deputy. He suggested the party's MPs vote on the matter rather than party members as currently required by party rules. Without the replacement of Duncan Smith, the party "has not a ghost of a chance of winning the next election" he said. Duncan Smith was removed the following year. In the 2005 party leadership election, Heseltine backed young moderniser David Cameron. Following Cameron's election to the leadership he set up a wide-ranging policy review. Chairmen of the various policy groups included ex-Chancellor Kenneth Clarke and other former Cabinet ministers John Redwood, John Gummer, Stephen Dorrell and Michael Forsyth as well as ex-leader Iain Duncan Smith. Heseltine was appointed to head the cities task force having been responsible for urban policy twice as Environment Secretary under Thatcher and Major. In 2008 Heseltine took part in the BBC Wales programme Coming Home about his Welsh family history. He said in this programme that he regarded Wales as his home and identified strongly with his Welsh ancestry.
== Biography == Madeleine-Angelique was born in Paris on 22 November 1684 to the actor Paul Poisson. Madeleine-Angélique married a Spanish nobleman, Don Gabriel de Gomez, thinking he was rich. When she discovered her husband was burdened with debt, she turned to writing as a hope to escape poverty. Her first a tragedy, Habis, was released in 1714 to much critical appeal, being played at the Comédie-Française with a revival in 1732. Between 1722 and 1772, Gomez published eight editions of Les Journées amusantes, with the work being translated into English by Eliza Haywood. While most of her work was published under the name Madame de Gomez (Mme de Gomez), some of her works have been published under the pseudonym M.P.V.D.G. She died in Saint-Germain-en-Laye on 28 December 1770 at the age of 86.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.